Clinical Trial Update: Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial of sorafenib in hepatocellular carcinoma patients who have undergone liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Nexavar) (Sorafenib)

Snippet

Sponsor: Columbia University | Conditions: Hepatocellular Cancer | Phase 1 | Status: COMPLETED